Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

New England Journal of Medicine - Tập 381 Số 26 - Trang 2497-2505 - 2019
Jean‐Claude Tardif1, Simon Kouz1, David D. Waters1, Olivier F. Bertrand1, Rafael Díaz1, Aldo P. Maggioni1, Fausto J. Pinto1, Réda Ibrahim1, Habib Gamra1, Ghassan S. Kiwan1, Colin Berry1, José López‐Sendón1, Petr Ošťádal1, Wolfgang Köenig1, Denis Angoulvant1, Jean C. Grégoire1, Marc-André Lavoie1, Marie‐Pierre Dubé1, David Rhainds1, Mylène Provencher1, Lucie Blondeau1, Andreas Orfanos1, Philippe L. L’Allier1, Marie‐Claude Guertin1, François Roubille1
1From the Montreal Heart Institute (J.-C.T., R.I., J.C.G., M.-A.L., M.-P.D., D.R., P.L.L.) and the Montreal Health Innovations Coordinating Center (M.P., L.B., A.O., M.-C.G.), Montreal, Centre Hospitalier Régional de Lanaudière, Joliette (S.K.), and Institut de Cardiologie et Pneumologie de Québec, Quebec City (O.F.B.) - all in Canada; San Francisco General Hospital, San Francisco (D.D.W.); Estudios Clínicos Latinoamérica, Rosario, Argentina (R.D.); Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence, Italy (A.P.M.); Santa Maria University Hospital (Centro Hospitalar Universitário Lisboa Norte), Centro Académico de Medicina de Lisboa, Centro Cardiovascular da Universidade de Lisboa, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal (F.J.P.); Fattouma Bourguiba University Hospital, Monastir, Tunisia (H.G.); Bellevue Medical Center, Beirut, Lebanon (G.S.K.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, and NHS Greater Glasgow and Clyde, Glasgow, United Kingdom (C.B.); Hospital Universitario La Paz, Universidad Autónoma de Madrid, Instituto de Investigación La Paz, Centro de Investigación Biomédica en Red-Enfermedades Cardiovasculares, Madrid (J.L.-S.); Cardiovascular Center, Na Homolce Hospital, Prague, Czech Republic (P.O.); Deutsches Herzzentrum München, Technische Universität München, and DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, and Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm - all in Germany (W.K.); Centre Hospitalier Universitaire (CHU) de Tours and Équipe d'Accueil 4245 Transplantation Immunité Inflammation Loire Valley Cardiovascular Collaboration, Tours University, Tours (D.A.), and PhyMedExp (Physiologie et Médecine Expérimentale du Cœur et des Muscles), Université de Montpellier, INSERM, Centre National de la Recherche Scientifique, Cardiology Department, CHU de Montpellier, Montpellier (F.R.) - all in France.

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1056/NEJMra043430

10.1056/NEJMoa1707914

10.1056/NEJMoa1809798

10.1038/nature02393

Perico N, 1996, J Am Soc Nephrol, 7, 594, 10.1681/ASN.V74594

10.1002/art.22938

10.2174/1568010053622984

10.1161/CIRCULATIONAHA.105.542738

10.1016/j.jacc.2012.10.027

10.1080/01621459.1999.10474144

10.1002/ejhf.29

10.1214/aos/1176345976

10.1080/01621459.1989.10478874

10.1111/1467-9868.00259

10.1002/(SICI)1097-0258(19970430)16:8<833::AID-SIM538>3.0.CO;2-2

10.1016/S0197-2456(00)00043-X

10.1002/(SICI)1097-0258(19970430)16:8<925::AID-SIM545>3.0.CO;2-2

10.1002/sim.2310

10.1016/j.csda.2008.04.009

10.1111/j.1365-2710.2008.00927.x